New Amsterdam Sciences Announces Pre-IND Phase 2 Submission with FDA Coronavirus Treatment Acceleration Program for NAS150

Scottsdale, AZ,  May 14th, 2021 – New Amsterdam Sciences, a privately held company, announces the filing of the Company’s newly provided materials and data with the FDA’s coronavirus treatment acceleration program as a pre-Investigation New Drug Phase 2 submission. The FDA submission is for the advancement of the Company’s therapeutic agent candidate NAS150 for the treatment […]

Is it possible to prevent and cure the COVID-19 virus with molecular hydrogen inhalation therapy?

June 9th, 2020 – COVID-19 has spread rapidly worldwide affecting over 5 million COVID-19 patients worldwide. In effort to treat and prevent COVID-19, multiple medical-associated organizations have been searching for a cure for this virus. In search of an effective treatment for this virus, molecular hydrogen inhalation therapy may be a viable contender for naturally alleviating […]